MX347513B - Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa. - Google Patents

Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.

Info

Publication number
MX347513B
MX347513B MX2015014313A MX2015014313A MX347513B MX 347513 B MX347513 B MX 347513B MX 2015014313 A MX2015014313 A MX 2015014313A MX 2015014313 A MX2015014313 A MX 2015014313A MX 347513 B MX347513 B MX 347513B
Authority
MX
Mexico
Prior art keywords
therapy
renal failure
blood
solute
failure blood
Prior art date
Application number
MX2015014313A
Other languages
English (en)
Inventor
Kenneth Leypoldt John
Lo Ying-Cheng
Akonur Alp
Ugar Agar Baris
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of MX347513B publication Critical patent/MX347513B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1613—Profiling or modelling of patient or predicted treatment evolution or outcome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1619—Sampled collection of used dialysate, i.e. obviating the need for recovery of whole dialysate quantity for post-dialysis analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0496—Urine
    • A61M2202/0498—Urea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/15—Detection of leaks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient

Abstract

Un sistema de terapia sanguínea de falla renal incluye: (i) una máquina de terapia sanguínea de falla renal; (ii) una prescripción de terapia para un paciente tratado a través de la máquina de terapia sanguínea de falla renal para remover un soluto de la sangre del paciente; (iii) una prueba que incluye múltiples muestras de sangre tomadas en múltiplos tiempos durante una terapia de prueba para determinar los niveles de concentración del soluto a cada uno de los múltiples tiempos; y (iv) un dispositivo programado para utilizar un modelo cinético para el soluto en una primera instancia con al menos uno de los niveles de concentración del soluto para estimar al menos un parámetro estimado del paciente. El dispositivo además está programado para permitir que un usuario determine al menos uno de una duración de terapia, una frecuencia de terapia, una velocidad de flujo del dializado o una velocidad de flujo de sangre para la prescripción de terapia.
MX2015014313A 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa. MX347513B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32511310P 2010-04-16 2010-04-16
PCT/US2011/032736 WO2011130669A1 (en) 2010-04-16 2011-04-15 Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis

Publications (1)

Publication Number Publication Date
MX347513B true MX347513B (es) 2017-04-28

Family

ID=44041518

Family Applications (4)

Application Number Title Priority Date Filing Date
MX2012012062A MX2012012062A (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2012012061A MX2012012061A (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2015014313A MX347513B (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2022001536A MX2022001536A (es) 2010-04-16 2012-10-16 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
MX2012012062A MX2012012062A (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
MX2012012061A MX2012012061A (es) 2010-04-16 2011-04-15 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022001536A MX2022001536A (es) 2010-04-16 2012-10-16 Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.

Country Status (10)

Country Link
EP (3) EP2558966B1 (es)
JP (8) JP5747072B2 (es)
AU (2) AU2011239488B2 (es)
BR (1) BR112012026361A2 (es)
CA (2) CA2796505C (es)
CO (3) CO6660434A2 (es)
ES (2) ES2802609T3 (es)
MX (4) MX2012012062A (es)
NZ (2) NZ602996A (es)
WO (2) WO2011130669A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132219B2 (en) 2010-04-16 2015-09-15 Baxter International Inc. Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
US8868350B2 (en) 2010-04-16 2014-10-21 Baxter International Inc. Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
MX361881B (es) * 2013-08-16 2018-12-18 Baxter Int Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria.
DE102014005122A1 (de) * 2014-04-08 2015-10-08 Fresenius Medical Care Deutschland Gmbh Verfahren zur Abschätzung der Behandlungsdauer einer Pertionealdialyse-Behandlung
US10525182B2 (en) 2014-10-10 2020-01-07 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
JP7086926B2 (ja) 2016-07-18 2022-06-20 ネクステージ メディカル インコーポレイテッド フローバランシングの装置、方法、及びシステム
US11865243B2 (en) 2016-08-30 2024-01-09 Nxstage Medical, Inc. Parameter monitoring in medical treatment systems
JP2019212249A (ja) * 2018-06-10 2019-12-12 大 益満 プログラム及び情報処理システム
CN115050238B (zh) * 2022-07-08 2024-03-12 卡斯柯信号有限公司 一种基于真实ctc系统的多模式切换仿真实训系统

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US5230702A (en) * 1991-01-16 1993-07-27 Paradigm Biotechnologies Partnership Hemodialysis method
ES2132260T3 (es) * 1992-10-13 1999-08-16 Baxter Int Modulo de muestreo de fluido.
JP2812460B2 (ja) * 1995-10-04 1998-10-22 日機装株式会社 血液浄化モニタ装置
JP3402360B2 (ja) * 1998-08-21 2003-05-06 株式会社ジェイ・エム・エス 腹膜透析システム
AUPP790898A0 (en) * 1998-12-23 1999-01-28 Life Therapeutics Limited Renal dialysis
DE60204883T3 (de) * 2002-09-05 2013-10-24 Gambro Lundia Ab Steuerung für eine Blutbehandlungsvorrichtung
US20040048837A1 (en) * 2002-09-06 2004-03-11 Lazarus J. Michael Method for treatment of renal disease
JP4379027B2 (ja) * 2003-05-14 2009-12-09 株式会社ジェイ・エム・エス 腹膜透析および血液透析併用プランニング方法ならびに腹膜透析および血液透析併用プランニング装置
DE602005020697D1 (de) * 2005-06-09 2010-05-27 Gambro Lundia Ab Medizinische vorrichtung und verfahren zum einrichten einer medizinischen vorrichtung
DE102006045437A1 (de) * 2006-09-26 2008-04-03 Fresenius Medical Care Deutschland Gmbh Vorrichtung und Verfahren zur Vorgabe einer Dialysierflüssigkeitsrate oder Blutflussrate für eine extrakorporale Blutbehandlung
US9028691B2 (en) 2007-02-27 2015-05-12 Deka Products Limited Partnership Blood circuit assembly for a hemodialysis system
US20080253911A1 (en) 2007-02-27 2008-10-16 Deka Products Limited Partnership Pumping Cassette
US8042563B2 (en) 2007-02-27 2011-10-25 Deka Products Limited Partnership Cassette system integrated apparatus
US20090107335A1 (en) 2007-02-27 2009-04-30 Deka Products Limited Partnership Air trap for a medical infusion device
US8409441B2 (en) * 2007-02-27 2013-04-02 Deka Products Limited Partnership Blood treatment systems and methods
US8562834B2 (en) 2007-02-27 2013-10-22 Deka Products Limited Partnership Modular assembly for a portable hemodialysis system
US8393690B2 (en) 2007-02-27 2013-03-12 Deka Products Limited Partnership Enclosure for a portable hemodialysis system
EP2174292A1 (en) * 2007-08-03 2010-04-14 Koninklijke Philips Electronics N.V. A method, apparatus, computer-readable medium and use for pharmacokinetic modeling
US9514283B2 (en) 2008-07-09 2016-12-06 Baxter International Inc. Dialysis system having inventory management including online dextrose mixing
US8168063B2 (en) 2008-07-09 2012-05-01 Baxter International Inc. Dialysis system having filtering method for determining therapy prescriptions
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
US8062513B2 (en) * 2008-07-09 2011-11-22 Baxter International Inc. Dialysis system and machine having therapy prescription recall
US7981281B2 (en) 2008-07-09 2011-07-19 Baxter International, Inc. Dialysis system having regimen generation methodology
EP2163272B1 (en) * 2008-09-15 2014-06-25 B. Braun Avitum AG Device to early predict the Kt/V parameter in kidney substitution treatments
US8999169B2 (en) * 2008-10-17 2015-04-07 Fresenius Medical Care Holdings, Inc. Method of determining a phosphorus binder dosage for a dialysis patient

Also Published As

Publication number Publication date
EP2558967B1 (en) 2020-04-15
AU2011239488A1 (en) 2012-11-08
JP6043850B2 (ja) 2016-12-14
JP6018567B2 (ja) 2016-11-02
MX2022001536A (es) 2022-05-26
CO6620023A2 (es) 2013-02-15
JP2017094150A (ja) 2017-06-01
WO2011130668A1 (en) 2011-10-20
MX2012012062A (es) 2013-06-28
EP2558966B1 (en) 2014-07-16
JP2019188179A (ja) 2019-10-31
JP2024045513A (ja) 2024-04-02
NZ602996A (en) 2015-02-27
AU2011239488B2 (en) 2015-05-21
AU2011239489A1 (en) 2012-11-08
ES2802609T3 (es) 2021-01-20
MX2012012061A (es) 2013-06-28
JP6543279B2 (ja) 2019-07-10
JP7438257B2 (ja) 2024-02-26
JP5747072B2 (ja) 2015-07-08
EP2558967A1 (en) 2013-02-20
AU2011239489B2 (en) 2015-04-02
CA2796496A1 (en) 2011-10-20
CA2796505C (en) 2018-12-11
CA2796505A1 (en) 2011-10-20
JP7057321B2 (ja) 2022-04-19
JP2015165914A (ja) 2015-09-24
BR112012026361A2 (pt) 2019-09-24
EP3706134A1 (en) 2020-09-09
CO6660434A2 (es) 2013-04-30
EP2558966A1 (en) 2013-02-20
JP2015221383A (ja) 2015-12-10
CO6630153A2 (es) 2013-03-01
JP2013524893A (ja) 2013-06-20
ES2501715T3 (es) 2014-10-02
WO2011130669A1 (en) 2011-10-20
JP6078582B2 (ja) 2017-02-08
CA2796496C (en) 2018-03-20
JP2013524892A (ja) 2013-06-20
JP2022095842A (ja) 2022-06-28
NZ603010A (en) 2014-05-30

Similar Documents

Publication Publication Date Title
MX2022001536A (es) Prediccion y optimizacion de terapia para terapia sanguinea de falla renal, especialmente hemodialisis en casa.
PL1993632T3 (pl) Urządzenie i sposób nadzoru dostępu do pacjenta, zwłaszcza dostępu do naczynia przy pozaustrojowej obróbce krwi
HK1165253A1 (en) Apparatus for detecting moisture for an apparatus for monitoring the access to a patient, in particular for monitoring the vascular access during extracorporeal blood treatment
WO2008033978A3 (en) Method for using photoplethysmography to optimize fluid removal during renal replacement therapy by hemodialysis or hemofiltration
MX2019003646A (es) Sistema y metodo para realizar modalidades de dialisis alternativa y secuencial de sangre y peritoneo.
WO2013101292A3 (en) Fluid volume monitoring for patients with renal disease
MX365492B (es) Control de un dispositivo de agua a traves de una interfase de usuario de maquina de dialisis.
GB2469950A (en) Dialysis system with recirculating dialysis fluid
EA201492106A1 (ru) Способ и устройство для контроля экстракорпоральной обработки крови пациента
ZA201005724B (en) Method and device for monitoring a vascular access and extracorporeal blood treatment device comprising a device for monitoring a vascular access
DE602007008544D1 (de) Vorrichtung zur Bestimmung des Reduktionsverhältnisses oder des Kt/V-Verhältnisses einer Nierenersatzbehandlung
ATE420678T1 (de) Dialysemaschine mit einer einrichtung zur bestimmung der dialysedosis
SG10201600502XA (en) Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood
TR201820019T4 (tr) Metilglioksal hidroimidazolonun (MGH1) belirlenmesi aracılığıyla diyabet yönetiminin geliştirilmesine yönelik yöntem ve kit.
JP2013524893A5 (es)
WO2014049560A3 (en) Extracorporeal blood treatment apparatus and method of setting an extracorporeal blood treatment
PT2429606E (pt) Método e dispositivo para otimização de um tratamento de sangue extracorporal
BR112013007046A2 (pt) método para a otimização do consumo de dialisato em uma unidade de tratamento sanguíneo e aparato para o tratamento sanguíneo
WO2009022988A3 (en) Vhz for diagnosis and treatment of cancer
WO2011131358A3 (de) Verfahren und vorrichtung zur bestimmung des fistelflusses einer fistel für die dialysebehandlung
WO2012075222A3 (en) Method of identifying when a patient undergoing hemodialysis is at increased risk of death
MX2013012083A (es) Biomarcadores para el tratamiento de mieloma multiple.
CN203123141U (zh) 可调式透析专用防污器
UA77634U (ru) Способ консервативного лечения венозных тромбозов
Lippi et al. PLASMA LEVELS OF HOMOCYSTEINE IN NEPHROPATIC DOGS SUBMITTED TO INTERMITTENT HAEMODIALYSIS